LCG
ANIP icon

Lisanti Capital Growth’s ANI Pharmaceuticals ANIP Stock Holding History

Lisanti Capital Growth’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-30,379
Closed -$2.4M – 107
2025
Q4 		$2.4M Sell
30,379
-52,175
-63% -$4.52M 0.57% 75
2025
Q3 		$7.56M Sell
82,554
-12,611
-13% -$1.03M 1.85% 5
2025
Q2 		$6.21M Sell
95,165
-10,260
-10% -$668K 1.72% 12
2025
Q1 		$7.06M Buy
105,425
+78,515
+292% +$4.69M 2.1% 3
2024
Q4 		$1.49M Buy
26,910
+11,990
+80% +$688K 0.36% 91
2024
Q3 		$890K Sell
14,920
-36,185
-71% -$2.21M 0.23% 107
2024
Q2 		$3.25M Buy
51,105
+19,020
+59% +$1.23M 0.78% 62
2024
Q1 		$2.22M Buy
+32,085
New +$1.94M 0.54% 73

Other funds holding ANIP

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return